Monofer (Ferric Derisomaltose)

Ferric derisomaltose, the active ingredient in Monofer, is a Iron (III) carbohydrate complex presented as a solution for injection for intravenous use. It treats iron deficiency anemia in adults and pediatric patients where oral iron is ineffective or not tolerated.

GNH USA supplies Monofer as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable access to essential intravenous iron therapy for patients in need. The company ensures quality compliance and timely delivery across global markets.

Monofer is used to treat iron deficiency anemia, a condition characterized by insufficient iron for normal red blood cell production.

- Iron deficiency anemia: rapid replenishment of iron stores and increase in hemoglobin levels. - Chronic kidney disease‑associated anemia: provides intravenous iron to support erythropoiesis when oral iron is insufficient. - Pre‑operative anemia: corrects iron deficiency before surgery to reduce the need for blood transfusion.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Headache: transient pain often resolving without intervention. - Injection site pain: localized discomfort at the infusion site. - Transient hypertension: brief increase in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hypotension: marked drop in blood pressure that may cause dizziness or fainting. - Iron overload: excessive iron accumulation potentially leading to organ toxicity.

Before using Monofer, consider the following precautions: - Assess iron status: confirm diagnosis of iron deficiency anemia before administration. - Monitor for hypersensitivity: observe the patient during and after infusion for signs of allergic reaction. - Avoid rapid infusion rates: follow recommended administration guidelines to reduce adverse events. - Use with caution in active infection: iron may promote bacterial growth, so evaluate infection risk. - Contraindicated in known hypersensitivity to ferric derisomaltose or its excipients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Monofer may interact with other medicines as follows:

Major Interactions (Avoid): - Other intravenous iron preparations: concurrent use increases risk of iron overload. - Erythropoiesis‑stimulating agents without iron monitoring: may exacerbate hypertension. - High‑dose vitamin C: can increase free iron levels and potentiate toxicity.

Moderate Interactions (Monitor Closely): - Oral iron supplements: may interfere with absorption; separate administration times. - Antacids containing aluminum or magnesium: may affect stability of the iron complex. - Chelating agents (e.g., deferoxamine): may bind released iron and reduce therapeutic efficacy.